Psychological evaluation and support in COVID-19 critically ill patients: a feasibility study

Prével, Renaud; Coelho, Julien; Orieux, Arthur; Philip, Pierre; Gruson, Didier; Bioulac, Stéphanie

doi:10.1186/s13054-021-03642-1

Cited by 7 publications

(5 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Notwithstanding of some earlier evidence pointing to the association of female gender, previous psychiatric history, as well as ICU-specific factors (such as delirium, sedation, mechanical ventilation, LoS) with a higher prevalence of psychological symptoms in COVID-19 patients [ 1 , 27 , 28 , 31 , 33 , 51 ], no significant statistically differences were observed in this study, which may be partially explained by the small sample size.…”

Section: Discussioncontrasting

confidence: 94%

Depressive and Anxiety Symptoms in Severe COVID-19 Survivors: A Prospective Cohort Study

et al. 2022

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19) has rapidly spread worldwide, leading to increased concerns about long-term patients’ neuropsychiatric consequences. This study aims to describe the presence of depressive and anxiety symptoms in severe COVID-19 survivors and to identify associated baseline, in-hospital and post-discharge factors. This study is part of the MAPA longitudinal project conducted with severe COVID-19 patients admitted in Intensive Care Medicine Department (ICMD) of a University Hospital (CHUSJ) in Porto, Portugal. Patients with ICMD length of stay ≤ 24 h, terminal illness, major auditory loss or inability to communicate at follow-up assessment were excluded. All participants were assessed by telephone post-discharge (median = 101 days), with a comprehensive protocol assessing depressive and anxiety symptoms, cognition, Intensive Care Unit (ICU) memories recall and health-related quality of life. Out of a sample of 56 survivors (median age = 65; 68% males), 29% and 23% had depressive and anxiety symptoms, respectively. Depressive and anxiety symptoms were significantly more prevalent among younger survivors and were associated with cognitive complaints, emotional and delusions ICU memories and fear of having COVID-19 sequelae, sleep problems and pain after discharge (all p < 0.05). An important proportion of these survivors suffers from depression and anxiety symptoms post-discharge, namely younger ones and those who reported more cognitive complaints, ICU memories, fear of having COVID-19 sequelae, sleep problems and pain. These findings highlight the importance of psychological consequences assessment and planning of appropriate and multidisciplinary follow-up care after hospitalization due to COVID-19. Supplementary Information The online version contains supplementary material available at 10.1007/s11126-022-09998-z.

show abstract

Section: Discussioncontrasting

confidence: 94%

Depressive and Anxiety Symptoms in Severe COVID-19 Survivors: A Prospective Cohort Study

et al. 2022

View full text Add to dashboard Cite

show abstract

“…In Italy, 40% (19/47) of patients treated in the ICU had acute stress disorder [65], and in the United States, 25% (7/28) of patients had mild to moderate depression, and 57% had mild cognitive impairment [66]. However, the prevalence of prolonged mental health problems may be lower in some populations because in France, 6 months after hospital discharge, anxiety (22% (4/18)), depression (11% (2/19)), or PTSD (6% (1/18)) were observed [67].…”

Section: Pics Features and Epidemiology In Covid-19mentioning

confidence: 99%

Post-Intensive Care Syndrome and Its New Challenges in Coronavirus Disease 2019 (COVID-19) Pandemic: A Review of Recent Advances and Perspectives

Nakanishi

Liu

Kawakami

et al. 2021

JCM

View full text Add to dashboard Cite

Intensive care unit survivors experience prolonged physical impairments, cognitive impairments, and mental health problems, commonly referred to as post-intensive care syndrome (PICS). Previous studies reported the prevalence, assessment, and prevention of PICS, including the ABCDEF bundle approach. Although the management of PICS has been advanced, the outbreak of coronavirus disease 2019 (COVID-19) posed an additional challenge to PICS. The prevalence of PICS after COVID-19 extensively varied with 28–87% of cases pertaining to physical impairments, 20–57% pertaining to cognitive impairments, and 6–60% pertaining to mental health problems after 1–6 months after discharge. Each component of the ABCDEF bundle is not sufficiently provided from 16% to 52% owing to the highly transmissible nature of the virus. However, new data are emerging about analgesia, sedation, delirium care, nursing care, early mobilization, nutrition, and family support. In this review, we summarize the recent data on PICS and its new challenge in PICS after COVID-19 infection.

show abstract

“…The prevalence of anxiety was not higher among the COVID-19 patients compared to the control group, but these results underline the importance of prevention and post-intensive care follow-up with adequate nursing care, environmental management, and psychological therapy[ 24 ]. These consequences might be prevented by an adequate psychological support[ 25 ].…”

Section: Discussionmentioning

confidence: 99%

Intensive care-related loss of quality of life and autonomy at 6 months post-discharge: Does COVID-19 really make things worse?

et al. 2022

View full text Add to dashboard Cite

Objective To compare old patients hospitalized in ICU for respiratory distress due to COVID-19 with old patients hospitalized in ICU for a non-COVID-19-related reason in terms of autonomy and quality of life. Design Comparison of two prospective multi-centric studies. Setting This study was based on two prospective multi-centric studies, the Senior-COVID-Rea cohort (COVID-19-diagnosed ICU-admitted patients aged over 60) and the FRAGIREA cohort (ICU-admitted patients aged over 70). Patients We included herein the patients from both cohorts who had been evaluated at day 180 after admission (ADL score and quality of life). Interventions None. Measurements and main results A total of 93 COVID-19 patients and 185 control-ICU patients were included. Both groups were not balanced on age, body mass index, mechanical ventilation, length of ICU stay, and ADL and SAPS II scores. We modeled with ordered logistic regression the influence of COVID-19 on the quality of life and the ADL score. After adjustment on these factors, we observed COVID-19 patients were less likely to have a loss of usual activities (aOR [95% CI] 0.47 [0.23; 0.94]), a loss of mobility (aOR [95% CI] 0.30 [0.14; 0.63]), and a loss of ADL score (aOR [95% CI] 0.30 [0.14; 0.63]). On day 180, 52 (56%) COVID-19 patients presented signs of dyspnea, 37 (40%) still used analgesics, 17 (18%) used anxiolytics, and 14 (13%) used antidepressant. Conclusions COVID-19-related ICU stay was not associated with a lower quality of life or lower autonomy compared to non-COVID-19-related ICU stay.

show abstract

Psychological evaluation and support in COVID-19 critically ill patients: a feasibility study

Cited by 7 publications

References 5 publications

Depressive and Anxiety Symptoms in Severe COVID-19 Survivors: A Prospective Cohort Study

Depressive and Anxiety Symptoms in Severe COVID-19 Survivors: A Prospective Cohort Study

Post-Intensive Care Syndrome and Its New Challenges in Coronavirus Disease 2019 (COVID-19) Pandemic: A Review of Recent Advances and Perspectives

Intensive care-related loss of quality of life and autonomy at 6 months post-discharge: Does COVID-19 really make things worse?

Contact Info

Product

Resources

About